Peptides (in skincare)
Cosmetic peptides such as palmitoyl pentapeptide (Matrixyl), copper peptides and "Botox-like" acetyl hexapeptide-8 (Argireline) gave modest improvements in fine lines in small trials of 4 to 12 weeks, but only 6 of 15 clinical studies of collagen-signalling peptides had a placebo control and several trials were run by the makers, so the honest rating is limited. They are well tolerated in the trials we read.
This page is only about creams and serums: injectable or "research" peptides such as BPC-157 are a different thing, and the FDA says it lacks enough information to know whether compounded BPC-157 would harm people.
At a glance
Last reviewed 10 October 2026What it's used for
Evidence is rated per use. The same ingredient can be strong for one thing and traditional for another.
| Use | Evidence | What the research shows |
|---|---|---|
| Fine lines and wrinkles, signal peptides (palmitoyl pentapeptide)Compare remedies for skin → | Limited | In a 12-week, double-blind, split-face trial of 93 women aged 35 to 55, a moisturiser with 3 ppm palmitoyl pentapeptide (pal-KTTKS) reduced wrinkles and fine lines versus the same moisturiser alone on expert grading and image analysis. The authors worked for Procter & Gamble. A systematic review of studies of collagen-signalling peptides found only 6 of 15 had a placebo control and 5 were double-blind, and called the literature sparse with many methodological limitations. A 2026 meta-analysis of 19 randomised trials (1,341 people, oral and topical peptides) found only a modest pooled wrinkle effect (mean difference 0.27, p = 0.04), driven mainly by oral peptides, and inconsistent effects on elasticity.4,1,2 |
| Expression lines, acetyl hexapeptide-8 (Argireline, "Botox-like") | Limited | In the original report, a 10% emulsion reduced wrinkle depth by up to 30% over 30 days in healthy women, and in lab tests the peptide inhibited neurotransmitter release but with much lower efficacy than botulinum toxin. A randomised, placebo-controlled study of 60 Chinese adults (3 to 1 to argireline, applied twice daily to crow's feet for 4 weeks) rated 48.9% of the argireline group as improved against 0% on placebo, with lower roughness on skin replicas. Both are short, small studies; the trial numbers are not large enough to say how long an effect lasts, and nothing we read compared it with botulinum toxin injections in people.6,5 |
| Wrinkles and skin quality, copper peptide (GHK-Cu) | Limited | Much of the evidence is lab and animal work. A 2026 systematic review says the human literature is thin and fragmented, with most randomised trials small and on facial cosmetic creams. In the one randomised trial we read, 13 people who finished after CO2 laser resurfacing had no significant difference in redness, wrinkles or skin quality on objective measures with or without GHK-Cu, though their questionnaire scores for overall skin quality were higher (p = 0.04). We found no sound trial of copper peptides on ordinary ageing skin.8,7 |
How much
Ranges below are what studies used and what supplements commonly contain. They are not a recommendation for you. Start at the low end.
How people take it
Safety
Who should avoid
- Injected or "research" peptides such as BPC-157 — FDA flags immune-reaction risk and too little safety data
- Expecting Botox-like results from a cream — lab data show lower efficacy than the toxin
- Pregnancy and breastfeeding — we found no data on cosmetic peptides
Known interactions
Questions people ask
Do peptides work for skin?
Modestly and with weak evidence. A palmitoyl pentapeptide moisturiser reduced fine lines over 12 weeks in 93 women, but the trial came from the maker, and a systematic review found only 6 of 15 studies of such peptides used a placebo control.
A 2026 meta-analysis of 19 randomised trials found only a modest wrinkle effect, driven by oral rather than topical peptides.
Is Argireline really "Botox in a bottle"?
No. It was designed to mimic part of how botulinum toxin blocks nerve signals, and a 10% emulsion reduced wrinkle depth by up to 30% in 30 days in the original report. The lab data show much lower efficacy than the toxin, and the human trials are small and short (60 people over 4 weeks in a randomised study).
What are the side effects of skincare peptides?
In the trials we read they were well tolerated: the meta-analysis of 19 randomised trials reported minimal adverse events, the pentapeptide trial found it well tolerated and the original Argireline report reported no primary irritation at high doses in its safety tests. Trials were short, so long-term safety is unknown.
What about injectable or "research" peptides like BPC-157?
This page does not cover them and they are not cosmetics. On its compounding page the FDA says that compounded BPC-157 may carry a risk of immune reactions and that it lacks enough safety information to know whether the drug would cause harm in humans.
Ask a doctor before using any injected peptide, and avoid products sold as "not for human consumption".
Sources (9)
- Systematic review Michalek IM, Lelen-Kaminska K, Caetano Dos Santos FL. Peptides stimulating synthesis of extracellular matrix used in anti-ageing cosmetics: are they clinically tested? A systematic review of the literature. Australas J Dermatol. 2019.
- Systematic review Nukaly HY, Halawani IR, Irtaza HM, et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med. 2026.
- Review Pai VV, Bhandari P, Shukla P. Topical peptides as cosmeceuticals. Indian J Dermatol Venereol Leprol. 2017.
- Randomised controlled trial Robinson LR, Fitzgerald NC, Doughty DG, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005.
- Randomised controlled trial Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013.
- Laboratory and clinical study Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002.
- Randomised controlled trial Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006.
- Systematic review Najafi N, Maatouk H, Vardanyan KG, Vartanian KB, Agrawal DK. A systematic review of the mechanisms and therapeutic applications of GHK-Cu in topical microneedle delivery: a case for expanded clinical trials. Arch Intern Med Res. 2026.
- Regulator guidance US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks (content current as of 22 April 2026).
Last reviewed 10 October 2026 · Next review April 2027 · How we rate evidence
Reader notes
Experiences and questions from readers, read by an editor before they appear. They are personal accounts, not evidence, and are not medical advice.